false
Catalog
Screening, Assessment, and Treatment Initiation fo ...
Presentation
Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video features Derek Blevins, an Assistant Professor of Psychiatry at Columbia University, discussing screening, assessment, and treatment initiation for substance use disorders. Blevins emphasizes the importance of training healthcare professionals in evidence-based practices for the prevention and treatment of opioid use disorders. He provides an overview of screening tools, such as the AUDIT-C and the CAGE questionnaire, for evaluating substance use. Blevins also discusses the stages of change and the need to tailor interventions based on a patient's readiness to change. He highlights the engagement phase of motivational interviewing, where open-ended questions, affirmations, reflections, and summaries are used to establish rapport with patients. Blevins emphasizes the value of harm reduction strategies and the availability of FDA-approved medications for alcohol, opioid, and tobacco use disorders. He discusses the ASAM criteria and different levels of care for treatment, ranging from inpatient to outpatient. Blevins concludes by providing referral resources and discussing two clinical case examples, demonstrating how to approach the discussion of substance use and assess the need for intervention or treatment. Overall, the video provides an informative overview of screening, assessment, and treatment options for substance use disorders.
Keywords
substance use disorders
screening
treatment initiation
evidence-based practices
opioid use disorders
motivational interviewing
harm reduction strategies
ASAM criteria
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English